Also categorized in BoardMoves:
What Lies Ahead For Chesapeake As McClendon Exits?
x hide permanently

BrainStorm Appoints Prof. Jacob Frenkel, Chairman of the Board of Directors

New York business news

NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cell technologies for neurodegenerative diseases, today announced the appointment of Jacob Frenkel, Ph.D., as Chairman of the Board of Directors...

Mentions: Nasdaq Board of Directors BrainStorm Cell Therapeutics Inc.